However, to date, putative therapeutics that were effective in this animal model have been ineffective in clinical trials in ALS patients, mooting the value of the SOD1 mouse for identifying therapeutics for familial and sporadic ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.